Cargando…
Procalcitonin has a poor prognosis value in critically ill patients with candidemia
Autores principales: | Charles, PE, Bruyère, R, Roche, H, Quenot, JP, Prin, S, Pavon, A, Dalle, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363449/ http://dx.doi.org/10.1186/cc10638 |
Ejemplares similares
-
Empirical antifungal treatment in the critically ill patients: how does it impact on the outcome?
por: Bruyère, R, et al.
Publicado: (2012) -
Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005) -
Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU
por: Bruyère, Rémi, et al.
Publicado: (2014) -
Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report
por: Charles, Pierre Emmanuel, et al.
Publicado: (2009) -
Procalcitonin: a prognostic marker for critically ill
por: Bhattacharyya, M, et al.
Publicado: (2009)